期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

人脑胶质瘤中Apaf-1基因启动子区甲基化的研究

Research on the Promoter Methylation of Apaf-1 Gene in Gliomas
下载PDF
导出
摘要 目的探讨凋亡蛋白酶活化因子1(Apaf-1)基因启动子区甲基化在脑胶质瘤中的表达及发生中的作用。方法应用半定量RT-PCR和甲基化特异性PCR分析方法分析37例脑胶质瘤及9例瘤旁非肿瘤脑组织中Apaf-1基因表达及启动子区甲基化情况。结果37例胶质瘤中23例Apaf-1mRNA表达下调,而瘤旁脑组织未发现Apaf-1mRNA表达明显下调或者上调;在Apaf-1基因表达明显下调的23例胶质瘤中15例出现甲基化,表达水平无明显下调的14例胶质瘤中仅4例出现甲基化,而瘤旁非肿瘤的9例脑组织中未检测到Apaf-1基因启动子甲基化。结论Apaf-1基因与脑胶质瘤的发生、发展相关,启动子区甲基化是该基因失活的重要机制。 Objcetive To investigate the effect and promoter methylation of Apaf-1 gene in progression of gliomas. Methods The expression and promoter methylation of Apaf-1 gene were detected by semi-quantitative RT-PCR and Methylation specific PCR in 37 specimens of brain gliomas and 9 specimens of brain tissues near tumors. Results The expression of 23 specimens of glomas （ 23/37 ） was lower than that of the brain tissues near tumor; methylation specific PCR displayed that 15 specimens were methylated in promoter regions in 23 specimens gliomas,whose expression of Apaf-1 mRNA was down regulated. By contrast,only 4 of 14 gliomas without changes in Apaf-1 mRNA levels were methylated. Conclusion Apaf-1 plays a role in progression of gliomas. The Apaf-1 DNA methylation in promoter region might contribute to the decreased transcription of Apaf-1 in gliomas .
作者 吕涛 关俊宏 陈铎 魏翔泰 刘云会
机构地区 中国医科大学附属盛京医院神经外科
出处 《中国医科大学学报》 CAS CSCD 北大核心 2009年第2期133-135,共3页 Journal of China Medical University
关键词 胶质瘤 凋亡蛋白酶活化因子1基因 逆转录酶-聚合酶链反应 甲基化 glioma apoptotic protease activating factor-1 gene RT-PCR methylation
分类号 R730.264 [医药卫生—肿瘤]
  • 相关文献

参考文献13

  • 1段国升.脑胶质瘤临床治疗的进展[J].中华神经外科杂志,2004,20(2):85-87. 被引量：49
  • 2于士柱,孙兆明.胶质瘤细胞增殖及凋亡调控紊乱研究的进展[J].中华病理学杂志,2005,34(9):547-549. 被引量：5
  • 3Steinbach JP,Weller M. Apoptosis in gliomas: molecular mechanisms and therapeutic implications [J] . J Neurooncol,2004,70(2) : 245-254.
  • 4史怀璋,李钰,刘晓谦,宋学明,胡韶山,高成,吕冰洁,谢向晨,岳武.p53基因、PTEN基因协同对胶质瘤U251细胞系生长抑制作用的研究[J].中华神经外科杂志,2004,20(1):22-25. 被引量：7
  • 5Campioni M, Santini D, Tonini G. Role of Apaf- 1, a key regulator of apoptosis,in melanoma progression and chemoresistance [J ]. Exp Dennatol, 2005,14 ( 11 ) : 811-818.
  • 6Soengas MS, Capodieci P, Polsky D,et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma [J]. Nature,2001,409 (6817) :207-211.
  • 7Zou H,Henzel WJ,Liu XS,et al . Apaf-1 ,a human protein homologous to C. elegans CED-4,participates in cytochrome c-dependent activation of caspase-3 [ J ]. Cell, 1997,90(3 ) : 405-413.
  • 8Cain K, Bratton SB, Langlais C. Apaf-1 oligomerizes into biologically active approximately 700-kDa and inactive approximately 1.4-MDa apoptosome complexes [J] . J Biol Chem,2000,275 (9): 6067- 6070.
  • 9Lauber K,Appel HA,Schlosser SF. The adapter protein apoptotic protease-activating factor-1 (Apaf-1) is proteolytically processed during apoptosis [ J ]. J Biol Chem, 2001,276(32) : 29772-29781.
  • 10杨振华,蔡映云,于坚,揭志军,朱景德.肿瘤相关基因启动子甲基化在非小细胞肺癌细胞株中的作用研究[J].中国实用内科杂志：临床前沿版,2006,26(5):746-748. 被引量：4

二级参考文献47

  • 1Calogero A, Arcella A, De Gregorio G, et al. The early growth response gene EGR-1 behaves as a suppressor gene that is downregulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas. Clin Cancer Res, 2001, 7 : 2788-2796.
  • 2Watanabe T, Katayama Y, Yoshino A, et al. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course. Clin Cancer Res,2003, 9 : 4884-4890.
  • 3Watanabe T, Nakamura M, Yonekawa Y, et al. Promoter hypermethylation and homozygous deletion of the pl4ARF and p16INK4a genes in oligodendrogliomas. Aeta Neuropathol ( Berl),2001, 101 : 185-189.
  • 4Perry A, Anderl K, Borell TJ, et al. Detection of pl6, RB, CDK4,and p53 gene deletion and amplification by fluorescence in situ hybridization in 96 gliomas. Am J Clin Pathol, 1999, 112: 801-809.
  • 5Suzuki T, Maruno M, Wada K, et al. Genetic analysis of human glioblastomas using a genomic microarray system. Brain Tumor Pathol, 2004, 21: 27-34.
  • 6Nishikawa R, Sugiyama T, Nafita Y, et al. Immunohistochemical analysis of the mutant epidermal growth factor, delta EGFR, in glioblastoma. Brain Tumor Pathol, 2004, 21 : 53-56.
  • 7Mizoguchi M, Nutt CL, Mohapatra G, et al. Genetic alterations of phosphoinositide 3-kinase subunit genes in human glioblastomas.Brain Pathol, 2004, 14 : 372-377.
  • 8Fiano V, Ghimenti C, Imarisio S, et al. PAkt, cyclin D1 and p27/Kipl in glioblastomas with and without EGFR amplification and PTEN mutation. Anticancer Res, 2004, 24(5A) : 2643-2647.
  • 9Park KH, Lee J, Yoo CG, et al. Application of p27 gene therapy for human malignant glioma potentiated by using mutant p27. J Neurosurg, 2004 , 101: 505-510.
  • 10Cheung KJ Jr, Li G. The tumor suppressor ING1: structure and function. Exp Cell Res, 2001, 268: 1-6.

共引文献63

中国医科大学学报
2009年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部